Editorial: Multi-omics strategy toward identifying and managing hereditary and metabolic liver diseases

Editorial: Multi-omics strategy toward identifying and managing hereditary and metabolic liver diseases

Saved in:

Bibliographic Details
Main Authors:	Mingjie Wang, Sujun Zheng, Xinhua Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Genetics
Subjects:	multi-omics hereditary liver disease metabolic dysfunction associated steatotic liver disease machine learning big data
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2024.1520721/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01)

Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2024-12-01)

Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
by: Gong Feng, et al.
Published: (2025-03-01)

HEREDITARY DISEASES OCCURRING WITH LIVER DAMAGE (LECTURE)
by: Elena Anatolievna Tkachuk, et al.
Published: (2024-03-01)

Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD
by: Jesse Pustjens, et al.
Published: (2024-12-01)

Sequential Diagnostic Approach Using FIB-4 and ELF for Predicting Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Yeo-Wool Kang, et al.
Published: (2024-11-01)

Exploring the epidemiology and awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among health sciences students in an academic health care institute in India
by: Umasankari S., et al.
Published: (2024-12-01)

Role of waist circumference, body mass index and high-sensitivity C-reactive protein in pediatric steatotic liver disease: A cross-sectional study
by: Qiaoling Wu, et al.
Published: (2025-01-01)

Predictors of Significant Fibrosis Among People Living with HIV with Metabolic Dysfunction- Associated Steatotic Liver Disease
by: Thaninee Prasoppokakorn, et al.
Published: (2024-12-01)

Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
by: Ludovico Abenavoli, et al.
Published: (2024-09-01)

Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma
by: Melchor Alpízar Salazar, et al.
Published: (2025-01-01)

Editorial: Unraveling the links between nutrients and metabolic dysfunction-associated liver disease: insights and implications
by: Bruno Ramos-Molina, et al.
Published: (2024-11-01)

Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Myrsini Orfanidou, et al.
Published: (2024-12-01)

Effect of a Ketogenic Diet on Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Progression: A Randomized Controlled Trial
by: Sakkarin Chirapongsathorn, et al.
Published: (2025-01-01)

Metabolic dysfunction-associated steatotic liver disease
by: Chieh Chen, et al.
Published: (2024-12-01)

Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
by: Zhifeng Gao, et al.
Published: (2025-01-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease and Alcohol-Associated Liver Disease: Liver DNA Methylation Analysis—A Systematic Review
by: Daniela Stols-Gonçalves, et al.
Published: (2024-11-01)

Advances in non-invasive diagnosis of metabolic dysfunction-associated fatty liver disease
by: WANG Ziqian, et al.
Published: (2024-07-01)

FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease
by: Mário Reis Álvares-da-Silva, et al.
Published: (2025-01-01)

The correlation between heavy metal ions in blood and metabolic dysfunction-associated steatotic liver disease from 1999 to 2018 based on NHANES data
by: Haijun Ma, et al.
Published: (2025-01-01)

Correlation between family function and self-management abilities in patients with metabolic dysfunction-associated steatotic liver disease
by: Yueying Zhu, et al.
Published: (2025-01-01)

The moderating effect of dietary fiber intake on the association between sleep pattern and liver fibrosis in metabolic dysfunction-associated steatotic liver disease: a study from NHANES
by: Guoqing Jia, et al.
Published: (2024-12-01)

An overview of pathogenesis of metabolic dysfunction-associated steatotic liver disease
by: Shahid Habib, et al.
Published: (2024-11-01)

The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease
by: Anna E. Płatek, et al.
Published: (2023-09-01)

Serum Irisin, Myostatin, and Myonectin Correlate with Metabolic Health Markers, Liver Disease Progression, and Blood Pressure in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Hypertension
by: Anna F. Sheptulina, et al.
Published: (2024-10-01)

Consistency analysis of two US techniques for evaluating hepatic steatosis in patients with metabolic dysfunction-associated steatotic liver disease
by: Fei Chen, et al.
Published: (2025-01-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
by: Jaehyun Bae, et al.
Published: (2024-11-01)

Non-alcoholic fatty liver disease and the gut microbiota in adolescents: is there a relationship?
by: Doaa El Amrousy, et al.
Published: (2024-11-01)

Sleeve-gastrectomy results in improved metabolism and a massive stress response of the liver proteome in a mouse model of metabolic dysfunction-associated steatohepatitis
by: Andreas Kroh, et al.
Published: (2024-11-01)

Editorial: Leveraging multi-omics approaches to understand and manage gastrointestinal and hepatic diseases
by: Isis Trujillo-Gonzalez, et al.
Published: (2024-12-01)

Augmenter of Liver Regeneration Crotonylation Assists in Mitochondria-ER Contact to Alleviate Hepatic SteatosisSummary
by: Xiao-lin Wang, et al.
Published: (2025-01-01)

Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience
by: Thanikan Sukaram, et al.
Published: (2025-01-01)

The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies
by: Li Jun Wang, et al.
Published: (2025-01-01)

Combi-Elastography versus Transient Elastography for Assessing the Histological Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Yun Kyu Lee, et al.
Published: (2024-11-01)

Performance of Noninvasive Indices for Discrimination of Metabolic Dysfunction-Associated Steatotic Liver Disease in Young Adults
by: Jaejun Lee, et al.
Published: (2025-01-01)

From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease
by: Mi Zhou, et al.
Published: (2025-01-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Patients—The Relationship with Platelets Indicators
by: Danusia Onișor, et al.
Published: (2024-12-01)

Insulin resistance has closer correlation with the occurrence of metabolic dysfunction associated steatotic liver disease diagnosed by liver biopsy
by: Weihua Cao, et al.
Published: (2024-11-01)

Role and therapeutic perspectives of extracellular vesicles derived from liver and adipose tissue in metabolic dysfunction-associated steatotic liver disease
by: Wandi Li, et al.
Published: (2024-12-01)

Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Yiying Pei, et al.
Published: (2025-01-01)